VONISH 0.2 TABLET

Product Description

VONISH 0.2 TABLET Powered by Voglibose (0.2mg) for Effective Diabetes Management

VONISH 0.2 TABLET contains Voglibose 0.2mg, a trusted alpha-glucosidase inhibitor used to manage postprandial blood sugar spikes in Type 2 diabetes mellitus. It slows down carbohydrate absorption in the intestine, helping to maintain glycemic control when used alongside diet and exercise.

Key Benefits:

• Helps control post-meal blood glucose levels

• Supports comprehensive Type 2 diabetes management

• Suitable for long-term use under medical supervision

Ideal For:
Pharmaceutical wholesalers, medical distributors, hospital pharmacies, and bulk procurement for diabetic care programs.